IndraLab
Statements
Flecainide activates SCN5A. 12 / 12
|
12
reach
"In contrast, they exerted more noticeable effects particularly in the RV of Scn5a +/- hearts, where the DeltaVERP was significantly increased (from 9.1 +/-1.1 to 21 +/-0.9 ms, p < 0.05, n = 6) by flecainide and significantly decreased (to 4.5 +/-0.5 ms, p < 0.05, n = 6) by quinidine."
reach
"Fourthly, the pro- and anti-arrhythmic agents flecainide and quinidine both increased VERPs in both WT and Scn5a +/- hearts in all regions, although the effect was more pronounced with quinidine than flecainide (e.g. 39.9 +/-0.9 ms before drug to 45.3 +/-2.6 ms with flecainide and to 73.3 +/-1.5 ms with quinidine, p < 0.05, n = 6 for the RV in Scn5a +/-; Fig."
reach
"On the other hand, the conduction slowing in RyR2 S/S mice was quantitatively similar to that observed in heterozygous Na + channel Na v 1.5-subunit knock-out (SCN5A +/-) mice, or WT mice treated with flecainide, pointing to the possibility that drugs which further compromise CV or excitability may be even proarrhythmic."